DAY ONE / MARCH 27, 2018
[su_spacer size=”30″] [su_accordion] [su_spoiler title=”7:45 am / Registration Opens” style=”fancy”] Registration and Breakfast[/su_spoiler] [su_spoiler title=”8:45 am / Conference Welcome” style=”fancy”] Susan Marlin, President and CEO, Clinical Trials Ontario
[/su_spoiler] [su_spoiler title=”9:00 am / Opening Remarks” style=”fancy”] The Honourable Reza Moridi, Minister of Research, Innovation and Science
[/su_spoiler] [su_spoiler title=”9:15 am / Keynote: Clinical Trials in the Age of Disruption” style=”fancy”] Clinical Trials in the Age of Disruption
[su_spacer size=”10″] As in industry, disruptive innovation has become a powerful force for change in health care. As a long time ER physician, broadcaster and observer of modern medical culture, Dr. Brian Goldman knows a lot about that. In this keynote, Dr. Goldman defines and explains the concepts behind disruptive innovation, and gives recent examples in of disruption in health care. He talks about the potential impact of disruptive innovation on clinical trials, including the impact of big data on clinical research.
[su_spacer size=”10″] Brian Goldman, ER Physician, Author and Radio Broadcaster (CBC’s White Coat, Black Art)
[/su_spoiler] [su_spoiler title=”10:00 am / Panel: The Evolving Clinical Research Environment” style=”fancy”] Panel: The Evolving Clinical Research Environment
[su_spacer size=”10″] This session will focus on key drivers of change in the clinical research environment. The panel will discuss how we can adapt to these changes and how patients, healthcare and our economy will be impacted now and in the future.
[su_spacer size=”10″] Jason Field (Moderator), President and CEO, Life Sciences Ontario
Brian Goldman, ER Physician, Author and Radio Broadcaster (CBC’s White Coat, Black Art)
Ed Dybka, Past-President, AstraZeneca Canada Inc., CTO Board Member
Benjamin Haibe-Kains, Scientist, UHN
Bev Heim-Myers, CEO, Huntington Society of Canada
Allan O’Dette, Chief Investment Officer, Ontario Investment Office
Jennifer Zelmer, President and CEO, Azimuth Health Group [/su_spoiler] [su_spoiler title=”10:45 am / Coffee and Networking Break” style=”fancy”] Coffee and Networking Break
[/su_spoiler] [su_spoiler title=”11:00 am / The Future of Health: From Cost Center to Value and Wealth Creator” style=”fancy”] The Future of Health: From Cost Center to Value and Wealth Creator
[su_spacer size=”10″] Zayna Khayat, Futures Strategist, Saint Elizabeth
[/su_spoiler] [su_spoiler title=”11:30 am / Collaboration Fosters Innovation Adoption” style=”fancy”] MaRS EXCITE Collaboration Fosters Innovation Adoption
[su_spacer size=”10″] Shahira Bhimani, Director, MaRS EXCITE
[/su_spoiler] [su_spoiler title=”12:00 pm / Lunch & Networking” style=”fancy”] Lunch & Networking
[/su_spoiler] [su_spoiler title=”1:30 am / Developing the Ebola Vaccine: A Lesson in Preparedness” style=”fancy”] Developing the Ebola Vaccine: A Lesson in Preparedness
[su_spacer size=”10″] Francis Plummer, Professor of Medicine and Medical Microbiology, University of Manitoba, and Scientific Director General, National Microbiology Laboratory, Public Health Agency of Canada
Interviewed by Dawn Richards, Director, Patient & Public Engagement, Clinical Trials Ontario
[/su_spoiler] [su_spoiler title=”2:00 pm / Coffee and Networking Break” style=”fancy”] Coffee and Networking Break
[/su_spoiler] [su_spoiler title=”2:30 pm / Panel: Innovation and Ethical Considerations in Clinical Trial Design” style=”fancy”] Panel: Innovation and Ethical Considerations in Clinical Trial Design
[su_spacer size=”10″] This session will focus on current and emerging trends in clinical trial design, how trials are evolving to meet the changing needs of patients, researchers, regulators and the healthcare system and how we can ensure that patient safety is always protected through stringent ethical frameworks.
[su_spacer size=”10″]
Raphael Saginur (Moderator), Chair, Ottawa Health Sciences Research Ethics Board
[su_spacer size=”10″] Integrating Clinical Trials with Best Practices and Quality Improvement: The Path ForwardPaul Karanicolas, Surgical Oncologist and Scientist, Odette Cancer Centre, Sunnybrook Health Sciences Centre
[su_spacer size=”10″] Ethical Issues in Pragmatic Trials: New Designs, New Challenges
Charles Weijer, Professor and Canada Research Chair in Bioethics, Western University
[su_spacer size=”10″] Rethinking Pragmatic Trials: The Experience of the REaCT Program in Cancer
Dean Fergusson, Senior Scientist & Director, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Professor, Departments of Medicine, Surgery & Epidemiology and Community Medicine, University of Ottawa.
[su_spacer size=”10″] [/su_spoiler] [su_spoiler title=”3:45 pm / Panel: Finding and Joining Clinical Trials – Experiences and Learnings” style=”fancy”] Panel: Finding and Joining Clinical Trials – Experiences and Learnings
[su_spacer size=”10″] Clinical trials simply don’t happen without participants. What do we understand about the specific opportunities and challenges that exist for people who wish to find and join a clinical trial? We’ll hear from a patient, caregiver, health charity and family physician who will shed light on those experiences, and present some initiatives and resources that have been created to help potential participants find and join a clinical trial.
[su_spacer size=”10″] Making it Easier for Patients to Understand and Participate in Clinical Trials
Bev Heim-Myers (Moderator), CEO, Huntington Society of Canada
[su_spacer size=”10″] How Clinical Trial Reform Can Help People With Lethal Diseases Extend Their Lives and Live Well
John-Peter Bradford, CEO, Life Saving Therapies Network
[su_spacer size=”10″] Finding out About Trials in Family Medicine: How Family Practice Based Research Networks and their Data Can Help
Michelle Greiver, Acting Director, University of Toronto Practice-Based Research Network (UTOPIAN), Adjunct Scientist, Institute for Clinical Evaluative Sciences
[su_spacer size=”10″] Navigating Through Neuroblastoma and Therapy Induced Myelodysplastic Syndrome
Kirby Kim, Caregiver Representative and Contributing Member, Neuroblastoma Canada
[su_spacer size=”10″] A Patient’s Perspective Navigating the Clinical Trial Process – Challenges and Positive Outcomes
Tina Ceroni, Clinical Trials Ontario Patient and Public Engagement Advisory Group Member
[su_spacer size=”10″]
Clinical Trial Support Center Services: Patient Experiences Using the Information Resource Center
Sarah Khan, Patient Education & Support Manager – Ontario Region, Leukemia & Lymphoma Society of Canada – Clinical Trials Support Centre
[/su_spoiler] [su_spoiler title=”4:45 pm / Reception” style=”fancy”] Reception
[/su_spoiler] [/su_accordion] [su_spacer size=”35″]
DAY TWO / MARCH 28, 2018
[su_spacer size=”30″] [su_accordion] [su_spoiler title=”8:00 am / Breakfast and Networking” style=”fancy”] Breakfast and Networking[/su_spoiler] [su_spoiler title=”8:40 am / Welcome to Day 2″ style=”fancy”] Susan Marlin
[/su_spoiler] [su_spoiler title=”9:00 am / Opening Remarks” style=”fancy”] Robert Bell, Ontario Deputy Minister of Health and Long-Term Care
[/su_spoiler] [su_spoiler title=”9:10 am / Keynote: Anticipating Patient Engagement’s Impact on the Evolution of Clinical Research” style=”fancy”] Keynote: Anticipating Patient Engagement’s Impact on the Evolution of Clinical Research
[su_spacer size=”10″] An examination of the current global operating environment for clinical research and specific areas where patient engagement practices and initiatives are being implemented. Measures of the expected and actual return on patient engagement will be presented. This session will also explore anticipated landscape changes — both short- and long-term — as patient engagement practices become more deeply embedded in the clinical research process.
[su_spacer size=”10″] Ken Getz, Director, Sponsored Research Programs and Research Associate Professor, Tufts Center for the Study of Drug Development
[/su_spoiler] [su_spoiler title=”10:45 am / Coffee and Networking Break” style=”fancy”] Coffee and Networking Break
[/su_spoiler] [su_spoiler title=”11:00 am / Panel: Exploring Models of Patient Engagement” style=”fancy”] Panel: Exploring Models of Patient Engagement
[su_spacer size=”10″] Patient engagement with clinical trials remains a hot topic, and for many, uncharted territory. A variety of perspectives (patient, pharma, academic, and government-funded) will share their efforts related to ensuring patients and caregivers are engaged with clinical trials, including the evaluation of that engagement. National and international initiatives demonstrate a breadth of ways to leverage patient and caregiver voices with clinical trials, all aimed at creating more robust trials and outcomes.
[su_spacer size=”10″] Ken Getz (Moderator), Director, Sponsored Research Programs and Research Associate Professor, Tufts Center for the Study of Drug Development
[su_spacer size=”10″] Patient Group Pathways to Cancer Clinical Trials
Barry Stein, President and CEO, Colorectal Cancer Canada
[su_spacer size=”10″] Chamber Music to Symphony: Integrating Patient Community Insights in Medicine Development Through a Cycle of Internal and External Engagement
Roslyn Schneider, Global Patient Affairs Lead, Pfizer
[su_spacer size=”10″] Advancing the Science of Patient Engagement Through Evaluation
Julia Abelson, Professor, Health Research Methods, Evidence, and Impact, McMaster University
[su_spacer size=”10″] Including Patients in the CADTH Scientific Advice Program: Ask, Listen, Advise
Ken Bond, Director, Patient Engagement, Ethics and International Affairs, Canadian Agency for Drugs and Technologies in Health
[su_spacer size=”10″] Patient Engagement and a Clinical Study in the Making – From Theory to Practice
Chantal Lacasse, Senior Clinical Operations Manager, Clinical Research, AbbVie
[/su_spoiler] [su_spoiler title=”12:00 pm / Lunch and Networking” style=”fancy”] Lunch and Networking
[/su_spoiler] [su_spoiler title=”1:00 pm / Special Guest, Dr. Molly Shoichet” style=”fancy”] Dr. Molly Shoichet, Ontario’s first Chief Scientist [/su_spoiler] [su_spoiler title=”1:30 pm / Panel: Big Data in Healthcare: Advancing Big Opportunities and Managing Privacy Risks” style=”fancy”] Panel: Big Data in Healthcare: Advancing Big Opportunities and Managing Privacy Risks
[su_spacer size=”10″] In a fast evolving era of big data, tremendous opportunities exist to advance our abilities to understand, prevent and treat disease. This session will highlight potential strategies for leveraging existing data and developing new sources and infrastructure to improve healthcare. The session will also explore associated privacy and security issues and how they may be addressed responsibly and efficiently to advance research opportunities.
[su_spacer size=”10″] Genomics in a Global Learning Health System
Peter Goodhand (Moderator), President of the Ontario Institute for Cancer Research and Executive Director of the Global Alliance for Genomics and Health
[su_spacer size=”10″]
Realizing the Opportunities: Using Ontario’s Health Data as a Driver to Improve Healthcare and Outcomes
Michael Schull, President and CEO, Institute of Clinical Evaluative Sciences
[su_spacer size=”10″]
Collaborative Health Research and Privacy Compliance in the Age of Intelligence Systems
Reza Samavi, Assistant Professor, Department of Computing and Software, MSc eHealth Program Coordinator, McMaster University
[su_spacer size=”10″]
How Can we Build a Health Data Ecosystem in Canada?
Michael Duong, Director, Medical Affairs – Evidence Generation, Roche
[su_spacer size=”10″]
Regulating the Use of Personal Health Information in Big Data Research
Joshua Shaw, Health Policy Analyst, Information and Privacy Commissioner of Ontario
[/su_spoiler]
[su_spoiler title=”3:00 pm / Coffee and Networking Break” style=”fancy”]
Coffee and Networking Break
[/su_spoiler]
[su_spoiler title=”3:15 pm / Panel: Streamlining Clinical Trials Conduct” style=”fancy”]
Streamlining Clinical Trials Conduct
[su_spacer size=”10″]
The clinical trials community continues to advance ways to streamline the conduct of clinical trials and make Ontario and Canada better locations to conduct trials. This session will review recent advances in streamlining and opportunities for continued improvement in clinical trial conduct.
[su_spacer size=”10″]
Making the Case for a Single pan-Canadian Research Ethics Review for Childhood Cancer Studies
James Witlock, Division Head and Women’s Auxiliary Millennium Chair in Haematology/Oncology, The Hospital for Sick Children, Senior Associate Scientist in the Child Health Evaluative Sciences Program, SickKids Research Institute
[su_spacer size=”10″]
Innovative Approaches to Multi-centre Academic Clinical Trials in Canada: Accomplishing More with Less!
Lauren Kelly, Clinical Trialist, George & Fay Yee Centre for Healthcare Innovation
[su_spacer size=”10″]
Streamlining the Review and Resolution of Privacy Issues
Holly Longstaff, Research Privacy Advisor, Provincial Health Services Authority, Ethicist, BC Cancer Research Ethics Board
[su_spacer size=”10″]
How do we Forge Ahead? Key Learnings from “No Site Left Behind” Workshop
A review of key learning and opportunities ahead identified in the CTO pre-conference workshop that focused on strategies for maximizing clinical trial start-up efficiency
Karri Venn, President, Research, LMC|Manna Research
[/su_spoiler]
[su_spoiler title=”4:50 pm / Closing Remarks” style=”fancy”]
Susan Marlin
[/su_spoiler]
[su_spoiler title=”5:00 pm / Conference Concludes” style=”fancy”]
Conference Concludes
[/su_spoiler]
[/su_accordion]